A novel study reveals predictive factors for developing severe COVID-19 that can be used by physicians to identify high risk hypertensive COVID-19 cases and determine appropriate treatment approach to achieve best possible clinical outcomes.
The present study identified four different DCM phenogroups associated with significant differences in clinical presentation, underlying molecular profiles and outcome, paving the way for a more personalized treatment approach.
A novel Cardiac Peri‑Operative Transfusion Trigger Scoring system offered a practical and straightforward guideline of perioperative blood transfusion in patients with CAD.
A simple count of widely available SDH may be a novel approach to identify individuals at high risk of incident CHD events that could be used in the course of clinical care.
The study support rigorous adherence to COVID-19 prevention strategies in obese individuals of all ages.
The study demonstrated that patients without significant PH and dominant post-capillary PH have a good prognosis after TTVR.
